You just read:

Glenmark Pharmaceuticals Receives ANDA Approval for Ranolazine Extended-Release Tablets, 500 mg and 1,000 mg

News provided by

Glenmark Pharmaceuticals Ltd

09 Jul, 2019, 11:38 IST